NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay MRD Assay at AACR 2022
Press Release
Read More
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
Press Release
Read More
NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
Press Release
Read More
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer
Press Release
Read More
Talking Cancer Blog: A Conversation with Holly Smithson, Athena CEO & Diversity Champion
Blog
Read More
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
Press Release
Read More